Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.36 |
| ▸ | SMPD2 | O60906 | 1/20 | 0.35 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22645617 | 1.00 | OR51E2 (0.36) | OR51E2SMPD2PDE4A | |
| SCHEMBL3862558 | 0.83 | CHRNB2 (0.32) | — | |
| SCHEMBL3425122 | 0.81 | GABRR1 (0.33) | OR51E2SMPD2 | |
| SCHEMBL2450587 | 0.81 | TDP1 (0.39) | — | |
| SCHEMBL31544538 | 0.81 | CA2 (0.31) | — | |
| SCHEMBL3180399 | 0.79 | OR51E2 (0.39) | OR51E2SMPD2PDE4A | |
| SCHEMBL15049991 | 0.78 | TET2 (0.41) | — | |
| SCHEMBL22288093 | 0.78 | — | — | |
| SCHEMBL15049990 | 0.78 | TET2 (0.41) | — | |
| SCHEMBL8950943 | 0.78 | ALOX15 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11365350-B2 | Silane compound | SK INNOVATION CO., LTD. (KR) | 2022-06-21 | — | — | US | disclosed |
| US-20200377794-A1 | SILANE COMPOUND | SK INNOVATION CO., LTD. (KR) | 2020-12-03 | — | — | US | disclosed |
| US-10836962-B2 | Etchant composition, method of etching insulating film, method of manufacturing semiconductor device, and silane compound | SK INNOVATION CO., LTD. (KR) | 2020-11-17 | — | — | US | disclosed |
| US-5585391-A | Hydroxyl ions as unique therapeutic agents and compounds that modulate these ions, compositions employing these agents, therapeutic methods for using such agents and processes for preparing them | FHJ SCIENTIFIC, INC. (US) | 1996-12-17 | — | — | US | disclosed |
| US-5574050-A | Hydroxyl ions as unique therapeutic agents and processes for preparing them | FHJ SCIENTIFIC, INC. (US) | 1996-11-12 | — | — | US | disclosed |
| EP-0725636-A1 | HYDROXYL IONS AS UNIQUE THERAPEUTIC AGENTS AND COMPOUNDS THAT MODULATE THESE IONS, COMPOSITIONS EMPLOYING THESE AGENTS, THERAPEUTIC METHODS FOR USING SUCH AGENTS AND PROCESSES FOR PREPARING THEM | FHJ SCIENTIFIC, INC. (US) | 1996-08-14 | — | — | EP | disclosed |
| US-5514808-A | Hydroxyl ions as unique therapeutic agents and compounds that modulate these ions | FHJ SCIENTIFIC, INC (US) | 1996-05-07 | — | — | US | disclosed |
| WO-1995010272-A1 | HYDROXYL IONS AS UNIQUE THERAPEUTIC AGENTS AND COMPOUNDS THAT MODULATE THESE IONS, COMPOSITIONS EMPLOYING THESE AGENTS, THERAPEUTIC METHODS FOR USING SUCH AGENTS AND PROCESSES FOR PREPARING THEM | FHJ SCIENTIFIC, INC. (US) | 1995-04-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200377794-A1 | SILANE COMPOUND | C9, RIOK1, CCNA1 | OR51E2 509/4885SMPD2 4577/4885PDE4A 4765/4885 |
| US-11365350-B2 | Silane compound | C9, RIOK1, CCNA1 | OR51E2 509/4885SMPD2 4577/4885PDE4A 4765/4885 |
| US-10836962-B2 | Etchant composition, method of etching insulating film, method of manufacturing semiconductor device, and silane compound | C9, PIK3C2B, PIK3C2A | OR51E2 423/4885SMPD2 3345/4885PDE4A 4141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.